Last reviewed · How we verify

Dihuang Baoyuan Granules

Beijing Supreme Life Pharmaceutical Technology Co., Ltd. · Phase 2 active Small molecule

Dihuang Baoyuan Granules is a Small molecule drug developed by Beijing Supreme Life Pharmaceutical Technology Co., Ltd.. It is currently in Phase 2 development. Also known as: prescription B.

At a glance

Generic nameDihuang Baoyuan Granules
Also known asprescription B
SponsorBeijing Supreme Life Pharmaceutical Technology Co., Ltd.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Dihuang Baoyuan Granules

What is Dihuang Baoyuan Granules?

Dihuang Baoyuan Granules is a Small molecule drug developed by Beijing Supreme Life Pharmaceutical Technology Co., Ltd..

Who makes Dihuang Baoyuan Granules?

Dihuang Baoyuan Granules is developed by Beijing Supreme Life Pharmaceutical Technology Co., Ltd. (see full Beijing Supreme Life Pharmaceutical Technology Co., Ltd. pipeline at /company/beijing-supreme-life-pharmaceutical-technology-co-ltd).

Is Dihuang Baoyuan Granules also known as anything else?

Dihuang Baoyuan Granules is also known as prescription B.

What development phase is Dihuang Baoyuan Granules in?

Dihuang Baoyuan Granules is in Phase 2.

Related